Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa...
21 insider purchases on record · latest filing 2024-05-20.
Insiders have also filed 113 sale transactions at ABEO.